The drug naïve group (3670 ppg/mL), but not the total PD group (3590 ppg/mL), had significantly higher concentration of neurogranin levels compared to the control group (3380 ppg/mL) (p = 0.023) (Table 2, Fig. 1c). This evidence concerns the gene NRGN and Parkinson disease.